Head of Data Management completes the London Marathon

Posted:
19
April 2005

Adam Walker shows his London Marathon medal

Adam Walker, Head of Richmond’s Data Management department, completed this year’s Flora London Marathon in 4 hours and 39 minutes! Adam raised £2,500 for the charity ‘Bliss’, but first he had to run 26.2 miles…Adam put in months of training to make sure he would be able to finish the course: “I started training in earnest in Mid December, and since then I’ve put in 4 runs and 2 cycling sessions every week! I trained for an hour before work on weekdays and ran 16 miles every Sunday. But even with that amount of training, running the marathon is very, very hard! After 20 miles, I really hit the wall and started walking for the first time. But I actually found it more painful to walk so I started running again! The crowd were fantastic and made a real difference over the last few miles. Once I was past Tower Bridge I knew the end was in sight and just kept telling myself to keep going. As I came into the final stretch, I could see my family cheering me on! It was, needless to say, a huge relief to finish!”The charity Bliss is dedicated to caring for premature babies: “This is the second year I’ve run to support Bliss, and I’m delighted to have raised a total of £5,000 from the two marathons. My daughter Amelie Grace was born 6 weeks prematurely and was in intensive care at the Sussex County Hospital, Brighton, for 4 weeks. I’m very grateful that Amelie was able to make a full recovery and is now a very healthy and happy toddler. I will continue to raise money for Bliss to help other families who find themselves in the same position.”To find out more about Bliss, visit www.bliss.org.ukTo sponsor Adam, visit www.justgiving.com/adam_walker

Latest news

Upcoming Event

The 41st Annual Scientific Meeting of the Japanese Society of Clinical Pharmacology and Therapeutics (JSCPT)

4 – 5 December 2020
The 41st Annual Scientific meeting focuses on international collaboration in the pursuit of drug discovery and drug development.
View event

Contributing to our community in 2020

December 17, 2020
Richmond Pharmacology has a long-standing tradition of supporting local, national, and international charities and 2020 is no exception.
Read more

Richmond Pharmacology supports Cardior Pharmaceuticals with the pioneering trial of an oligonucleotide-based drug in heart failure patients

December 14, 2020
Richmond Pharmacology is delighted to welcome the positive Phase Ib results of Cardior Pharmaceuticals lead compound CDR132L for heart failure.
Read more

Marking a milestone for gene editing

November 10, 2020
We are pleased to share that Richmond Pharmacology, in partnership with Intellia Therapeutics and the Royal Free Hospital, have treated the first patient in a landmark CRISPR/Cas9 clinical trial of NTLA-2001
Read more